See the Full Picture.
Published loading...Updated

Nuveen Asset Management LLC Sells 39,145 Shares of Janux Therapeutics, Inc. (NASDAQ:JANX)

Summary by defenseworld.net
Nuveen Asset Management LLC decreased its position in shares of Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) by 23.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 127,747 shares of the company’s stock after selling 39,145 shares during the period. Nuveen Asset Management LLC owned approximately 0.24% of Janux Therapeutics worth $6,840,000 at…

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

defenseworld.net broke the news in on Friday, May 30, 2025.
Sources are mostly out of (0)